Association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension

Mingfei Li; Ying Wang; Ndindam Ndiwane; Michelle B. Orner; Natalia Palacios; Dan Berlowitz; Lewis Kazis; Weiming Xia

Association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension

Mingfei Li
, Ying Wang
, Ndindam Ndiwane
, Michelle B. Orner
, Natalia Palacios
, Dan Berlowitz
, Lewis Kazis
, Weiming Xia

Mathematical Sciences

Research output: Contribution to journal › Article

Original language	English
Journal	PLOS ONE
Issue number	16(3)
State	Published - 2021

Cite this

@article{e881ee52265043878ef7f0a740637815,

title = "Association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension",

author = "Mingfei Li and Ying Wang and Ndindam Ndiwane and Orner, \{Michelle B.\} and Natalia Palacios and Dan Berlowitz and Lewis Kazis and Weiming Xia",

year = "2021",

language = "English",

journal = "PLOS ONE",

number = "16(3)",

}

TY - JOUR

T1 - Association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension

AU - Li, Mingfei

AU - Wang, Ying

AU - Ndiwane, Ndindam

AU - Orner, Michelle B.

AU - Palacios, Natalia

AU - Berlowitz, Dan

AU - Kazis, Lewis

AU - Xia, Weiming

PY - 2021

Y1 - 2021

UR - https://typeset.io/papers/the-association-of-covid-19-occurrence-and-severity-with-the-3dkuwcpdo4

M3 - Article

JO - PLOS ONE

JF - PLOS ONE

IS - 16(3)

ER -

Association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension

Other files and links

Cite this